<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

LSX USA White 500x 

   STRATEGY, INVESTMENT AND PARTNERING FOR LIFE SCIENCE EXECUTIVES   

 
2nd Annual Conference
7 - 8 October 2019
Convene Convention Center
Boston | USA
#LSXUSA

DOWNLOAD THE BROCHURE

Confirmed Partners

Goldman Sachs
Freshfields Bruckhaus Deringer

Peer-to-peer knowledge exchange, curated group meetings, and content to address the questions on the minds of CEOs

LSX World Congress USA

What is it and who is it for?

The LSX World Congress USA is a gathering of the industries foremost life science executive leaders.

Now in it’s second year, LSX USA follows the unique style and format of the LSX World Congress in London focusing on strategy, investment and partnering.

The three core pillars of our community are:

  • CxOs of life sciences companies
  • Heads of Pharma Business Development
  • VC and PE Investors

We address and look to find solutions to the respective challenges they face, and connect them with strategies, solutions and contacts to enable growth and development in their businesses.

LSX USA Venn 500x

Early Confirmed Speakers

Ted Tanner Jr., CTO and Chief Architect, Watson Health, IBM (1)

Ted Tanner Jr.
CTO and Chief Architect, Watson Health, IBM
IBM 300x

Melissa Fensterstock, Co-Founder and CEO, Landsdowne Labs

Melissa Fensterstock
Co-Founder and CEO, Landsdowne Labs
Landsdowne Labs

Carolyn Witte, Co-Founder and CEO, Tia

Carolyn Witte
Co-Founder and CEO, Tia
Tia 300x

Joel Wishkovsky, CEO, Simple Health

Joel Wishkovsky
CEO, Simple Contacts
Simple Contacts 300x

Todd Foley, Managing Partner, MPM Capital

Todd Foley
Managing Partner, MPM Capital
MPM Capital

Peter Dudek, Partner, MRL Ventures Fund

Peter Dudek
Partner, MRL Ventures Fund
MRL Ventures Fund

Priyanka Rohatgi, Managing Director, Head, Ipsen Ventures

Priyanka Rohatgi
Managing Director, Head, Ipsen Ventures
Ipsen Ventures

Agenda at a Glance

Forum - 7 October

09:00


1-2-1 Meetings

12:30


Lunch Break

13:30


Investor Forum


Early Stage CEO Forum


Growth Stage CEO Forum


Publicly Listed CEO Forum

17:30


Investor Drinks & Dinner


CEO Drinks & Dinner

Conference - 8th October

09:00


Keynote Plenary


1-2-1 Meetings

10:30


Conference


Pharma BD Forum


Licensing Strategies Workshop


Clinical Strategies Workshop


1-2-1 Meetings

12:30


Lunch Break

13:30


Conference


Pharma BD Forum


Exit Strategies Workshop


Market Access Strategies Workshop


1-2-1 Meetings

15:30


Plenary


1-2-1 Meetings

IPO Bootcamp - 9th October

09:00


The IPO Bootcamp is a full-day forum in which a team of some of the world’s foremost experts, advisers, bankers and consultants help 8 CEOs and CFOs navigate the how, what, where and when of a successful US IPO. The key USPs are a very high level and calibre of attendee and program, exclusivity, and a personalised approach.

Meet some of our 2018 speakers

Ivana Magovčević-Liebisch, EVP & Chief Business Officer, Ipsen

Ivana Magovčević-Liebisch

EVP & Chief Business Officer
Ipsen
Noubar Afeyan, Founder and CEO, Flagship Pioneering

Noubar Afeyan

Founder and CEO
Flagship Pioneering
Boris Zaitra, Global Head of M&A, Roche

Boris Zaitra

Global Head of M&A
Roche
Neil Exter, Partner, Third Rock Ventures

Neil Exter

Partner
Third Rock Ventures
Arjun Goyal, Co-Founder and Managing Director, VIDA Ventures

Arjun Goyal

Co-Founder and Managing Director
VIDA Ventures
James Kasuboski, Director, Boehringer

James Kasuboski

Director
Boehringer Ingelheim Venture Fund USA
Michal Silverberg, Managing Director, Novartis Venture Fund

Michal Silverberg

Managing Director
Novartis Venture Fund
Todd Foley, Managing Director, MPM Capital

Todd Foley

Managing Director
MPM Capital
Alexandra Glucksmann, CEO, Cedilla Therapeutics

Alexandra Glucksmann

CEO
Cedilla Therapeutics
Rob Brainin, CEO, WuXI NextCODE

Rob Brainin

CEO
WuXI NextCODE
Michael Sherman, SVP and Chief Medical Officer, Harvard Pilgrim Health Care

Michael Sherman

SVP and Chief Medical Officer
Harvard Pilgrim Health Care
ALEX DE WINTER Managing Director GE VENTURES

Alex de Winter

Managing Director
GE Ventures
PAUL BIONDI SVP Head of BD BRISTOL-MYERS SQUIBB

Paul Biondi

SVP, Strategy and Business Development
Bristol-Myers Squibb
Russ Johannesson, CEO, Glooko

Russ Johannesson

CEO
Glooko
NIGEL SHEAIL Global Head of M&A and BD&L NOVARTIS

Nigel Sheail

Global Head of M&A and BD&L
Novartis
DOUG GIORDANO VP Business Development PFIZER

DOUG GIORDANO

VP Business Development
PFIZER
VIEW ALL 2018 SPEAKERS

Network

Network

Biotech, medtech and deeptech CxOs will be coming to Boston and joined by investors and pharma to address key issues facing their businesses and the wider healthcare sector.

Partner

Partner

1-2-1 partnering is a key focus across the two days. Pre-event all attendees and see who is attending, message each other and book meetings to find investors, investment opportunities and connect with potential partners.

Learn

Learn

Understand the latest trends, forecasts and insights from leading investors, life science executives, pharma BD&L heads and industry KOLs through presentations and more informal workshops and group discussions.

LSX USA